Molecular analysis of nicotinic receptor expression in autism

Molecular Brain Research

Volumn 123, Issue 1-2, 2004, Pages 81-90

  Martin Ruiz, C M ^a,b   Lee, M ^a   Perry, R H ^a   Baumann, M ^a   Court, J A ^a   Perry, E K ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Autism; Developmental disorders; Disorders of the nervous system; mRNA expression; Nicotinic receptors; Protein; Radioligand binding

Indexed keywords

BUNGAROTOXIN; EPIBATIDINE; MESSENGER RNA; NICOTINIC RECEPTOR; RADIOLIGAND; RECEPTOR SUBUNIT;

ADULT; ARTICLE; AUTISM; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; MALE; MOLECULAR BIOLOGY; NEUROPATHOLOGY; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACETYLCHOLINE; ADULT; AUTISTIC DISORDER; BINDING, COMPETITIVE; BRAIN; BRAIN CHEMISTRY; CEREBELLUM; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PARIETAL LOBE; PROTEIN SUBUNITS; RADIOLIGAND ASSAY; RECEPTORS, NICOTINIC; RNA, MESSENGER; SYNAPSES; SYNAPTIC TRANSMISSION; UP-REGULATION;

EID: 1642273411     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2004.01.003     Document Type: Article

References (59)

1. Ahlsen G., Rosengren L., Belfrage M., Palm A., Haglid K., Hamberger A., Gillberg C. Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders. Biol. Psychiatry. 33:1993;734-743.
2. Bailey A., Luthert P., Dean A., Harding B., Janota I., Montgomery M., Rutter M., Lantos P. A clinicopathological study of autism. Brain. 121(Pt. 5):1998;889-905.
3. Baulac S., Huberfeld G., Gourfinkel-An I., Mitropoulou G., Beranger A., Prud'homme J.F., Baulac M., Brice A., Bruzzone R., LeGuern E. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat. Genet. 28:2001;46-48.
4. Bauman M.L., Kemper T.L. Neuroanatomic observations of the brain in autism. Bauman M.L., Kemper T.L. The Neurobiology of Autism. 1994;119-145 John Hopkins Univ. Press, Baltimore.
5. Blatt G.J., Fitzgerald C.M., Guptill J.T., Booker A.B., Kemper T.L., Bauman M.L. Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J. Autism Dev. Disord. 31:2001;537-543.
6. Buitelaar J.K., Willemsen-Swinkels S.H. Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy. Paediatr. Drugs. 2:2000;67-81.
7. Burghaus L., Schutz U., Krempel U., de Vos R.A., Jansen Steur E.N., Wevers A., Lindstrom J., Schroder H. Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. Mol. Brain Res. 76:2000;385-388.
8. Chugani D.C., Muzik O., Rothermel R., Behen M., Chakraborty P., Mangner T., da Silva E.A., Chugani H.T. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann. Neurol. 42:1997;666-669.
9. Clementi F., Fornasari D., Gotti C. Neuronal nicotinic receptors, important new players in brain function. Eur. J. Pharmacol. 393:2000;3-10.
10. Courchesne E., Press G.A., Yeung-Courchesne R. Parietal lobe abnormalities detected with MR in patients with infantile autism. AJR Am. J. Roentgenol. 160:1993;387-393.
11. Courchesne E., Karns C.M., Davis H.R., Ziccardi R., Carper R.A., Tigue Z.D., Chisum H.J., Moses P., Pierce K., Lord C., Lincoln A.J., Pizzo S., Schreibman L., Haas R.H., Akshoomoff N.A., Courchesne R.Y. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology. 57:2001;245-254.
12. Croonenberghs J., Delmeire L., Verkerk R., Lin A.H., Meskal A., Neels H., Van der Planken M., Scharpe S., Deboutte D., Pison G., Maes M. Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder. Neuropsychopharmacology. 22:2000;275-283.
13. Didier M., Berman S.A., Lindstrom J., Bursztajn S. Characterization of nicotinic acetylcholine receptors expressed in primary cultures of cerebellar granule cells. Mol. Brain Res. 30:1995;17-28.
14. Di Martino A., Tuchman R.F. Antiepileptic drugs: affective use in autism spectrum disorders. Pediatr. Neurol. 25:2001;199-207.
15. Fatemi S.H., Halt A.R. Altered levels of Bcl2 and p53 proteins in parietal cortex reflect deranged apoptotic regulation in autism. Synapse. 42:2001;281-284.
16. Fatemi S.H., Halt A.R., Stary J.M., Kanodia R., Schulz S.C., Realmuto G.R. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry. 52:2002;805-810.
17. Feng J., Sobell J.L., Heston L.L., Cook E.H. Jr., Goldman D., Sommer S.S. Scanning of the dopamine D1 and D5 receptor genes by REF in neuropsychiatric patients reveals a novel missense change at a highly conserved amino acid. Am. J. Med. Genet. 81:1998;172-178.
18. Flores C.M., Davila-Garcia M.I., Ulrich Y.M., Kellar K.J. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J. Neurochem. 69:1997;2216-2219.
19. Graham A., Court J., Martin-Ruiz C.M., Jaros E., Perry R., Volsen S.G., Bose S., Evans N., Ince P., Kuryatov A., Lindstrom J., Gotti C., Perry E.K. Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum. Neuroscience. 113:2002;493-507.
20. Herlenius E., Lagercrantz H. Neurotransmitters and neuromodulators during early human development. Early Hum. Dev. 65:2001;21-37.
21. Jamain S., Betancur C., Quach H., Philippe A., Fellous M., Giros B., Gillberg C., Leboyer M., Bourgeron T. Linkage and association of the glutamate receptor 6 gene with autism. Mol. Psychiatry. 7:2002;302-310.
22. Kim S.J., Veenstra-VanderWeele J., Hanna G.L., Gonen D., Leventhal B.L., Cook E.H. Jr. Mutation screening of human 5-HT(2B)receptor gene in early-onset obsessive-compulsive disorder. Mol. Cell. Probes. 14:2000;47-52.
23. Lassig J.P., Vachirasomtoon K., Hartzell K., Leventhal M., Courchesne E., Courchesne R., Lord C., Leventhal B.L., Cook E.H. Jr. Physical mapping of the serotonin 5-HT(7) receptor gene (HTR7) to chromosome 10 and pseudogene (HTR7P) to chromosome 12, and testing of linkage disequilibrium between HTR7 and autistic disorder. Am. J. Med. Genet. 88:1999;472-475.
24. Lavine N., Reuben M., Clarke P.B. A population of nicotinic receptors is associated with thalamocortical afferents in the adult rat: laminal and areal analysis. J. Comp. Neurol. 380:1997;175-190.
25. Lee M., Martin-Ruiz C.M., Graham A., Court J., Jaros E., Perry R., Iversen P., Bauman M., Perry E. Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain. 125:2002;1483-1495.
26. Lekman A., Skjeldal O., Sponheim E., Svennerholm L. Gangliosides in children with autism. Acta Paediatr. 84:1995;787-790.
27. Lindstrom J., Anand R., Peng X., Gerzanich V., Wang F., Li Y. Neuronal nicotinic receptor subtypes. Ann. N.Y. Acad. Sci. vol. 757:1995;100-116.
28. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
29. Maestrini E., Lai C., Marlow A., Matthews N., Wallace S., Bailey A., Cook E.H., Weeks D.E., Monaco A.P. Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. Am. J. Med. Genet. vol. 88:1999;492-496.
30. Malone R.P., Maislin G., Choudhury M.S., Gifford C., Delaney M.A. Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness. J. Am. Acad. Child Adolesc. Psych. 41:2002;140-147.
31. Martineau J., Herault J., Petit E., Guerin P., Hameury L., Perrot A., Mallet J., Sauvage D., Lelord G., Muh J.P. Catecholaminergic metabolism and autism. Dev. Med. Child Neurol. 36:1994;688-697.
32. Martin-Ruiz C.M., Court J.A., Molnar E., Lee M., Gotti C., Mamalaki A., Tsouloufis T., Tzartos S., Ballard C., Perry R.H., Perry E.K. Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. J. Neurochem. 73:1999;1635-1640.
33. Martin-Ruiz C.M., Piggott M., Gotti C., Lindstrom J., Mendelow A.D., Siddique M.S., Perry R.H., Perry E.K., Court J.A. Alpha and beta nicotinic acetylcholine receptors subunits and synaptophysin in putamen from Parkinson's disease. Neuropharmacology. 39:2000;2830-2839.
34. Martin-Ruiz C., Court J., Lee M., Piggott M., Johnson M., Ballard C., Kalaria R., Perry R., Perry E. Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types. Acta Neurol. Scand., Suppl. 176:2000;34-41.
35. McGehee D.S., Heath M.J., Gelber S., Devay P., Role L.W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 269:1995;1692-1696.
36. McQueen J.M., Heck A.M. Secretin for the treatment of autism. Ann. Pharmacother. 36:2002;305-311.
37. Muratori F., Cesari A., Casella C. Autism and cerebellum. An unusual finding with MRI. Panminerva Med. 43:2001;311-315.
38. Nelson K.B., Grether J.K., Croen L.A., Dambrosia J.M., Dickens B.F., Jelliffe L.L., Hansen R.L., Phillips T.M. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann. Neurol. 49:2001;597-606.
39. Perry E.K., Lee M.L., Martin-Ruiz C.M., Court J.A., Volsen S.G., Merrit J., Folly E., Iversen P.E., Bauman M.L., Perry R.H., Wenk G.L. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am. J. Psychiatry. 158:2001;1058-1066.
40. Philippe A., Guilloud-Bataille M., Martinez M., Gillberg C., Rastam M., Sponheim E., Coleman M., Zappella M., Aschauer H., Penet C., Feingold J., Brice A., Leboyer M. Analysis of ten candidate genes in autism by association and linkage. Am. J. Med. Genet. 114:2002;125-128.
41. Posey D.J., Guenin K.D., Kohn A.E., Swiezy N.B., McDougle C.J. A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders. J. Child Adolesc. Psychopharmacol. 11:2001;267-277.
42. Purcell A.E., Jeon O.H., Zimmerman A.W., Blue M.E., Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology. 57:2001;1618-1628.
43. Remington G., Sloman L., Konstantareas M., Parker K., Gow R. Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study. J. Clin. Psychopharmacol. 21:2001;440-444.
44. Ritvo E.R., Freeman B.J., Scheibel A.B., Duong T., Robinson H., Guthrie D., Ritvo A. Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC autopsy research report. Am. J. Psychiatry. 143:1986;862-866.
45. Rodier P.M., Ingram J.L., Tisdale B., Nelson S., Romano J. Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J. Comp. Neurol. 370:1996;247-261.
46. Rodier P.M., Ingram J.L., Tisdale B., Croog V.J. Linking etiologies in humans and animal models: studies of autism. Reprod. Toxicol. 11:1997;417-422.
47. Roth A.L., Shoop R.D., Berg D.K. Targeting alpha7-containing nicotinic receptors on neurons to distal locations. Eur. J. Pharmacol. 393:2000;105-112.
48. Schramm M., Falkai P., Tepest R., Schneider-Axmann T., Przkora R., Waha A., Pietsch T., Bonte W., Bayer T.A. Stability of RNA transcripts in post-mortem psychiatric brains. J. Neural Transm. 106:1999;329-335.
49. Steffenburg S., Gillberg C., Hellgren L., Andersson L., Gillberg I.C., Jakobsson G., Bohman M. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J. Child Psychol. Psychiatry. 30:1989;405-416.
50. Stromland K., Nordin V., Miller M., Akerstrom B., Gillberg C. Autism in thalidomide embryopathy: a population study. Dev. Med. Child Neurol. 36:1994;351-356.
51. Tordjman S., Gutknecht L., Carlier M., Spitz E., Antoine C., Slama F., Carsalade V., Cohen D.J., Ferrari P., Roubertoux P.L., Anderson G.M. Role of the serotonin transporter gene in the behavioral expression of autism. Mol. Psychiatry. 6:2001;434-439.
52. Wang D.X., Abood L.G. Expression and characterization of the rat alpha 4 beta 2 neuronal nicotinic cholinergic receptor in baculovirus-infected insect cells. J. Neurosci. Res. 44:1996;350-354.
53. Waterhouse L., Fein D., Modahl C. Neurofunctional mechanisms in autism. Psychol. Rev. 103:1996;457-489.
54. Whitaker-Azmitia P.M. Serotonin and brain development: role in human developmental diseases. Brain Res. Bull. 56:2001;479-485.
55. Whiting P.J., Liu R., Morley B.J., Lindstrom J.M. Structurally different neuronal nicotinic acetylcholine receptor subtypes purified and characterized using monoclonal antibodies. J. Neurosci. 7:1987;4005-4016.
56. Whiting P.J., Schoepfer R., Swanson L.W., Simmons D.M., Lindstrom J.M. Functional acetylcholine receptor in PC12 cells reacts with a monoclonal antibody to brain nicotinic receptors. Nature. 327:1987;515-518.
57. Williams G., King J., Cunningham M., Stephan M., Kerr B., Hersh J.H. Fetal valproate syndrome and autism: additional evidence of an association. Dev. Med. Child Neurol. 43:2001;202-206.
58. Wolf P., Hosli E., Roches J.C., Zumstein H.R., Heitz P., Hosli L. Histochemical investigations on the presence of acetylcholinesterase and succinic dehydrogenase in fetal human spinal cord and brain stem at different stages of development. Eur. Neurol. 13:1975;31-46.
59. Zoli M., Lena C., Picciotto M.R., Changeux J.P. Identification of four classes of brain nicotinic receptors using beta2 mutant mice. J. Neurosci. 18:1998;4461-4472.